IBS Next-Generation Therapies: Low FODMAP Diets, Neuromodulators, Digital Cognitive Behavioral Therapy, and Microbiome-Based Interventions

IBS Next-Generation Therapies: Low FODMAP Diets, Neuromodulators, Digital Cognitive Behavioral Therapy, and Microbiome-Based Interventions Review Abstract Background Irritable bowel syndrome (IBS) is a chronic disorder of gut–brain interaction characterized by abdominal pain associated with altered bowel habits. Conventional therapies often provide incomplete symptom relief, leading to

IBD: A Link To Cancer And Infection

IBD: A Link To Cancer And Infection Individuals diagnosed with inflammatory bowel disease (IBD) face higher susceptibility to malignancy and infection when compared to the general population. The primary objective of this study was to identify and describe risk factors associated with malignancy or serious infection in patients with IBD, with a

Gastrointestinal Diseases – Overview

GlobalRPh student writer Gastrointestinal diseases (aka GI disease or GI disorder) are those that affect the digestive tract (GI tract). This may include sections from the esophagus to the rectum, and the accessory digestive organs liver, gallbladder, and pancreas. Gastrointestinal diseases can be acute, chronic, or recurrent. It covers a wide

IBS Next-Generation Therapies: Low FODMAP Diets, Neuromodulators, Digital Cognitive Behavioral Therapy, and Microbiome-Based Interventions